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Received February 8, 2016; accepted April 28, 2016AbstractBackground: More than 50 different species of bacteria may live in a woman's vagina, with lactobacilli being the predominant microorganism
found in healthy adult females. Lactobacilli are relevant as a barrier to infection and are important in the impairment of colonization by
pathogens, owing to competitive adherence to adhesion sites in the vaginal epithelium and their capacity to produce antimicrobial compounds.
Methods: The aim of the present study was to demonstrate the inhibitory capability of Lactobacillus metabolites against Clostridium perfringens,
an anaerobic Gram-positive bacterium. These bacteria were isolated from vaginal swabs by using culture-dependent approaches, and the
bacteriostatic effect of Lactobacillus metabolites, extracted from different isolates, was assessed using a modified E test.
Results: Among the 100 vaginal swabs, 59 (59%) samples showed the presence of Lactobacillus strains and only one sample contained C.
perfringens. Lactobacillus metabolites demonstrated the significant potency of in vitro activity against C. perfringens, with minimal inhibitory
concentration values ranging from 15.6 mg/mL to 31.2 mg/mL.
Conclusion: This study suggests that women without vaginal Lactobacillus strains may be susceptible to nonindigenous and potentially harmful
microorganisms.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Lactobacillus strains are thought to play a major role in
protecting the vaginal environment from nonindigenous and
potentially harmful microorganisms. This is accomplished
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also known to produce other antimicrobial compounds besides
lactic acid, including target-specific bacteriocins,1 and broad-
spectrum hydrogen peroxide.2 Clostridium perfringens is an
anaerobic Gram-positive bacterium known to be a common
pathogen in humans, domestic animals, and wildlife, and is the
primary cause of clostridial enteric disease in domestic ani-
mals. C. perfringens has 10 rRNA operons and 18 poly-
morphic sites among the 16S rRNA genes.3e5 A common
feature of C. perfringens is the production of 17 exotoxins and
enterotoxin (CPE). C. perfringens is subdivided into five
toxinotypes (AeE). Isolates originating from humans with
gastrointestinal diseases carrying both cpb2 and cpe havesevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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wide genetic diversity of C. perfringens from isolates causing
enteric diseases in humans, based on pulsed field gel electro-
phoresis analysis. C. perfringens is part of the normal vaginal
flora of 127% of healthy women. Therefore, ascending
infection from the vagina to the uterus may occur.6 Under
appropriate conditions, the bacteria can cause endometritis
that leads to sepsis.10 Meanwhile, C. perfringens infection
may occur in the uterus, especially after abortions via the use
of contaminated surgical instruments.10 However, the impor-
tance of Lactobacillus has been shown in preventing infections
such as genital infections, urinary tract infections, and bacte-
rial vaginitis, which are caused by reducing Lactobacillus and
overgrowth of other microorganisms.11,12 Accordingly, this
study was conducted with the aim of assessing the inhibitory
capability of vaginal Lactobacillus metabolites against C.
perfringens isolated from a woman's vagina.
2. Methods2.1. Design of studyIn this research, 100 reproductive-age women who were
referred to the women's department of Imam Khomeini Hos-
pital in Ahvaz, Iran, were considered for this study. The in-
clusion criteria called for healthy married women who were
25e50 years of age. The exclusion criteria included cervix
injuries, previous abortion, and divorced women.
In a 35-year-old nonpregnant woman, the only bacterium
isolated from a cervicovaginal smear sample was C. per-
fringens. On physical examination, she had high fever (39C),
a small amount of necrotic tissue, and mild inflammation of
the uterus. The patient appeared anemic and icteric, although
her blood pressure and pulse rate were normal. On examina-
tion, her abdomen was normal and no free air was seen on
plain chest X-ray films. Blood tests showed evidence of mild
inflammation, with a white blood cell count of 14,150 mL and
a C-reactive protein level of 8.0 mg/dL. The cervicovaginal
smear samples were collected from vaginal swabs of women,
and the swabs were immediately placed in thioglycollate
transport medium (Hi Media, Laboratories, Mumbai, India)
and transported in ice bags to the university's laboratory. The
samples were incubated for 48 hours at 37C.2.2. Isolation of bacteriaThe collected swabs were placed on the selective medium
for lactobacilli, De ManeRogosaeSharpe (MRS) agar
(Conda, Madrid in Spain). The plates were incubated at 37C
for 24e48 hours under anaerobic conditions using a candle jar.
The Lactobacillus were presumptively identified by their
ability to grow well on MRS medium13 followed by differ-
ential biochemical tests including Gram staining, catalase test,
fermentation of glucose, maltose, and sucrose in order to
confirm the identification of Lactobacilli. Lactobacilli are rod-
shaped, Gram-positive, fermentative, facultative anaerobic or
microaerophilic organotrophs.Isolation of C. perfringens from the vagina was accom-
plished by spreading the cervical swabs on a blood agar me-
dium. Then plates were incubated anaerobically in a candle jar
with gas packed for a period of 24e48 hours at 37C.14 The
colonies that showed double zone hemolysis on blood agar
plates were considered C. perfringens. Thereafter, other
diagnostic tests including stormy clot, Nagler test, gelatin
hydrolysis test, and indole test were performed in order to
confirm the identification of C. perfringens.2.3. Antimicrobial compound extraction from
Lactobacillus spp.The isolated colonies of Lactobacillus grown on MRS agar
were transferred into 100 mL of MRS broth and incubated in
an anaerobic chamber at 37C for 5 days. Then, the antimi-
crobial compound was extracted using the three following
methods.
2.3.1. Method 1
After incubation, a part of the culture medium was directly
mixed with ethyl acetate (50:50) and then stirred using a
magnetic stirrer for 6 hours. The upper organic layer was
separated using a separating funnel and centrifuged at
6000 rpm for 15 minutes. Then the ethyl acetate layer was
removed and transferred into a clean flask. The extract was
pooled and dried in a rotary evaporator (Heidolph in
Schwabach, Germany) at 45C. The yield from the extract was
dissolved in methanol for antimicrobial susceptibility testing.
2.3.2. Method 2
The second part of the medium was shocked by immersion
in boiling water for 1 minute, and then placed in cold water for
3 minutes. Then, the extraction was followed by adding ethyl
acetate similar to the first method.
2.3.3. Method 3
The third part of the culture medium was stressed using an
ultrasonic device for 3 minutes (160 W); then, similar to the
first method, extraction of the antimicrobial compound was
performed.2.4. Determination of minimum inhibitory concentration
of Lactobacillus spp. extractsThe minimum inhibitory concentrations (MICs) of Lacto-
bacillus extracts against C perfringens isolates were deter-
mined using an improved E test method (AB Biodisk, Solna,
Sweden) in order to show the antimicrobial activity of isolated
Lactobacillus spp. In the improved E test, several AB Biodisks
impregnated with different dilutions of the extracts were used
instead of strips. In fact, it was a simulated version of the
standard E test.
The C. perfringens suspensions of freshly grown cultures
were prepared in sterile saline and adjusted to a density of
106 cells/mL, corresponding to 68e82% transmittance at
530 nm. The plate of MuellerHinton agar (Hi Media India in
Fig. 2. Antimicrobial activity of Lactobacillus against Clostridium perfringens
by modified E test.
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swab into the C. perfringens suspension and streaking it across
the agar surface in three directions. The plates were dried at an
ambient temperature for 15 minutes before applying the disks.
Eight sterile disks (6 mm) were placed in a line on the agar
surface. The Lactobacillus spp. extract was serially diluted in
methanol, and 10 mL of each dilution was separately used to
impregnate the disks. The plates were incubated for 24 hours
at 37C. The MIC values were read as the antimicrobial
concentrations at the points where dense colonial growth
intersected the disks. The test was performed in triplicate for
each culture.15
3. Results
A total of 59 Lactobacillus spp. strains and one strain of C.
perfringens were isolated from 100 vaginal swabs by using
different selective media and biochemical tests. The morpho-
logical and biochemical characteristics of all bacterial isolates
were tested according to Bergey's Manual of Determinative
Bacteriology.16
The antimicrobial activity of the extracted compounds from
10 Lactobacillus strains showed that the first method of
extraction using an ultrasonic device has more activity
compared with others. The obtained MICs from all tested
Lactobacillus strains based on the modified E test ranged from
15.6 mg/mL to 31.2 mg/mL (Figs. 1 and 2).
It should be mentioned that the inhibitory capability of
Lactobacillus metabolites against some vaginal/uterine
opportunistic bacteria were also assessed as an ancillary studyFig. 1. MIC and inhibition zone diameter of antimicrobial extract of Lactobacillus
inhibitory concentration.(Table 1). These pathogens included Candida albicans NCIM
7102, Staphylococcus aureus PTCC 1113, and Escherichia
coli PTCC 1533.
4. Discussion
C. perfringens, an anaerobic Gram-positive bacillus, is
found in normal human intestinal and vaginal flora in
approximately 25% of healthy women. The presence of C.
perfringens in the vagina or uterus can be lethal because of the
risk of developing sepsis and gas gangrene followed by genital
sores or vaginal fissures that lead to additional gynecological
examinations and even abortions. In cases involving gas
gangrene, the mortality rate ranges from 50% to 85%.17
Although few cases of clostridial gas gangrene associatedspp. against Clostridium perfringens using modified E test. MIC ¼ minimum
Table 1
MIC of antimicrobial extract of Lactobacillus spp. against Candida albicans
NCIM 7102, Staphylococcus aureus PTCC 1113, Escherichia coli PTCC
1533, using the modified E test.







Isolate-1 50.25 55.24 40.7
Isolate-2 100 90.8 80
Isolate-3 55 54 35
Isolate-4 65.77 70 55
Isolate-5 85 80.3 60.5
Isolate-6 35 40 30.3
Isolate-7 30 35.2 25
Isolate-8 55.47 55 40
Isolate-9 90.6 100 80
Isolate-10 55.32 55 45
MIC ¼ minimum inhibitory concentration.
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cation resulting in potentially fatal sepsis were possible out-
comes in most of those cases.
The vaginal ecosystem is dynamic and contains microbiota
that are protective against invading pathogens, including those
causing urinary tract infections and sexually transmitted in-
fections. Lactobacilli are the best-known bacteria of the
normal vaginal microbiota as a probiotic.18 Antonio et al19
reported that women who were not colonized with H2O2-
producing lactobacilli, such as Lactobacilli crispatus, Lacto-
bacilli iners, Lactobacilli jensenii, Lactobacilli gasseri and
Lactobacilli vaginalis, were 15 times more likely to have
bacterial vaginosis than women who were colonized by these
strains.19 In fact, owing to the rise of bacterial resistance
against antibiotics, scientists are looking to benefit from pro-
biotics in order to both strengthen the immune system and
infection prevention and control.20,21 Previously, in many
studies, the important role of vaginal lactobacilli as potential
probiotics has been shown against such pathogens as Candida
spp.,22 and the most common opportunistic bacterial (S.
aureus, E. coli, S. agalactiae, and Klebsiella pneumoniae).23
In this study, the antimicrobial effect of the extracted com-
pound of vaginal Lactobacilli was investigated on C. per-
fringens, in order to find the benefit of this probiotic to prevent
the spread of clostridial infection in the uterus, reduce mor-
tality, as well as reduce the use of antibiotics.
The results of this study showed that among the 100 vaginal
samples, only one (1%) contained C. perfringens. Such fre-
quency was reported to be 5% in the Jawetz book,24 1e27% of
women in some published articles10,17 and also 1e27% of
those patients who had optional abortions.25 Also, it was
showed that 59 (59%) of the samples were Lactobacillus
strains. These statistical results are consistent with other sta-
tistics that reported the prevalence of vaginal lactobacilli at a
rate of 50e80%.26 Amin et. al.27 reported the prevalence of
49.5%. In the present study, all vaginal Lactobacillus strains
showed significant antimicrobial activity (MIC ranged from
15.6 to 31.2 mg/ml) against C. perfringens like Amin's study
(MIC against S. aureus: 4 mg/ml, MIC against Candidaalbicans: 1 mg/ml).27 Coolborn28 could isolate 8 Lactic acid
bacteria from food sources and soil by using MRS medium
and then evaluated their antimicrobial activity against some
pathogenic bacteria with two methods of well-in agar and
paper disc method. He defined that Lactic acid bacteria with
inhibitory affinity over the bacterial indicators exhibited
varying degrees of inhibitory zones.
In the present study, ethyl acetate was used to obtain the
Lactobacillus extract from broth media similar to the antimi-
crobial extraction method of plants and also like Amin's
study.27 Extracts obtained from all three methods were able to
make zones of inhibition. However, inhibition zone diameter
was much less in the second and third method than in first
method. The weight of lactobacillus extract obtained from the
second and third methods was reduced, as compared to the
first method. In particular, it was reduced considerably more in
the second method. In other studies, researchers used the
filtered supernatant fluids from MRS liquid medium contain-
ing Lactobacillus cells as antimicrobial extract. In the ethyl
acetate extraction method, we tried to partially purify the
extract, and therefore the inhibition zones were much wider
than in other studies. In our study, Sodium hydroxide (NaOH)
was added to the extract in order to neutralize its PH. There-
fore, the antimicrobial activity of extract was not related to its
acidic nature. Moreover, the use of boiling method to obtain
the extract indicated that the antimicrobial activity of extract
was not related to bacteriocin (antibacterial proteins), which
confirmed the results of Rokka's study.29
This study suggested that women without vaginal Lacto-
bacillus strains might be susceptible to non-indigenous and
potentially harmful microorganisms. Moreover, if the normal
vaginal flora is not disturbed by antibiotics, vaginal lactoba-
cilli can prevent pathogen growth and C. perfringens
infections.
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